Evidence map›Paper›PMID 26578879›Full record

ArticleFrontiers in cellular neuroscience2015

Calretinin and parvalbumin in schizophrenia and affective disorders: a mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei.

Ralf Brisch, Hendrik Bielau, Arthur Saniotis, Rainer Wolf, Bernhard Bogerts, Dieter Krell, Johann Steiner, Katharina Braun, Marta Krzyżanowska, Maciej Krzyżanowski and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Ralf BrischDepartment of Forensic Medicine, Medical University of Gdańsk Gdańsk, Poland.
Hendrik BielauDepartment of Psychiatry and Psychotherapy, Otto-von-Guericke-University of Magdeburg Magdeburg, Germany.
Arthur SaniotisSchool of Medicine, The University of Adelaide Adelaide, SA, Australia ; Institute of Evolutionary Medicine, University of Zurich Zurich, Switzerland.
Rainer WolfDepartment of Psychiatry and Psychotherapy, Ruhr University Bochum Bochum, Germany.
Bernhard BogertsDepartment of Psychiatry and Psychotherapy, Otto-von-Guericke-University of Magdeburg Magdeburg, Germany ; Center for Behavioral Brain Sciences Magdeburg, Germany.
Dieter KrellDepartment of Psychiatry and Psychotherapy, Otto-von-Guericke-University of Magdeburg Magdeburg, Germany.
Johann SteinerDepartment of Psychiatry and Psychotherapy, Otto-von-Guericke-University of Magdeburg Magdeburg, Germany ; Center for Behavioral Brain Sciences Magdeburg, Germany.
Katharina BraunCenter for Behavioral Brain Sciences Magdeburg, Germany ; Department of Zoology/Developmental Neurobiology, Institute of Biology, Otto-von-Guericke-University of Magdeburg Magdeburg, Germany.
Marta KrzyżanowskaDepartment of Forensic Medicine, Medical University of Gdańsk Gdańsk, Poland.
Maciej KrzyżanowskiDepartment of Forensic Medicine, Medical University of Gdańsk Gdańsk, Poland.
Zbigniew JankowskiDepartment of Forensic Medicine, Medical University of Gdańsk Gdańsk, Poland.
Michał KaliszanDepartment of Forensic Medicine, Medical University of Gdańsk Gdańsk, Poland.
Hans-Gert BernsteinDepartment of Psychiatry and Psychotherapy, Otto-von-Guericke-University of Magdeburg Magdeburg, Germany.
Tomasz GosDepartment of Forensic Medicine, Medical University of Gdańsk Gdańsk, Poland.
Gdańsk Medical University · PLOtto-von-Guericke University Magdeburg · DECenter for Behavioral Brain Sciences · DERuhr University Bochum · DEUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe septal nuclei are important limbic regions that are involved in emotional behavior and connect to various brain regions such as the habenular complex. Both the septal nuclei and the habenular complex are involved in the pathology of schizophrenia and affective disorders.

methodsWe characterized the number and density of calretinin-immunoreactive neurons in the lateral, medial, and dorsal subregions of the septal nuclei in three groups of subjects: healthy control subjects (N = 6), patients with schizophrenia (N = 10), and patients with affective disorders (N = 6).

resultsOur mini-review of the combined role of calretinin and parvalbumin in schizophrenia and affective disorders summarizes 23 studies. We did not observe significant differences in the numbers of calretinin-immunoreactive neurons or neuronal densities in the lateral, medial, and dorsal septal nuclei of patients with schizophrenia or patients with affective disorders compared to healthy control subjects.

conclusionsMost post-mortem investigations of patients with schizophrenia have indicated significant abnormalities of parvalbumin-immunoreactive neurons in various brain regions including the hippocampus, the anterior cingulate cortex, and the prefrontal cortex in schizophrenia. This study also provides an explanation from an evolutionary perspective for why calretinin is affected in schizophrenia.

Indexed as

affective disorderscalretininevolution of the human brainparvalbuminpost-mortem studiesschizophreniaseptal nuclei

Identifiers

PMID26578879
PMCPMC4624860
OpenAlexW1878534994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.